We have fourteen deals this week, taking in TPG's €400 million European healthcare portfolio acquisition, a 214,000 sq ft Grade A laboratory completion in Oxford and Syngenta's $130 million biological sciences centre in Berkshire. Let's get into it.
In today's free edition:
🇩🇪 🇳🇱 TPG Real Estate acquires €400 million European healthcare portfolio
🇬🇧 Trinity by Breakthrough reaches practical completion in Oxford
🇮🇪 Taoiseach opens Glassworks Building One in Waterford
🇬🇧 Syngenta to invest $130 million in Jealott's Hill BioSTaR centre
🔒 For paying members only:
🇬🇧 Cambridge Science Park development opportunity hits market at £200 million
🇬🇧 Wellcome Genome Campus breaks ground on expansion
🇬🇧 STFC opens scale-up laboratory at Sci-Tech Daresbury
🇮🇪 Primary Health Properties increases its Irish portfolio value
🇪🇸 Greenvia Labs to open life sciences hub in Barcelona
🇫🇷 Enodia Therapeutics takes space at The HIVE in Villejuif
🇮🇪 Amgen growing its Dún Laoghaire campus
🇨🇭 Proof of the Sum and VILS develop masterplan for Getec Park Stein
🇬🇧 BioMed Realty lets two suites at Babraham Research Campus
🇩🇪 Leases renewed at Medical Center in Duisburg
Subscribe here to unlock.
Enjoy today's newsletter,
— Stephen Ryan (connect with me on LinkedIn)
Knight Frank Australia is bringing to market Helix Hub Innovation Precinct, Western Sydney
Currently under construction with completion due in Q4 2027, Helix Hub is a next generation pure alternatives asset that will deliver 16,849 sqm of education and life sciences space, complemented by 84 high-quality studio living units.
Backed by Built, a nationally trusted Tier-1 delivery partner with extensive experience delivering high-quality commercial projects and positioned at the epicentre of Western Sydney's rapidly expanding growth and innovation corridor, Helix Hub represents a once-in-market rarity to gain exposure to education, life sciences and living in a single asset.
With a 20-year lease already secured to the University of Wollongong and the remaining floors offering specialised, lab-enabled floorplates, Helix Hub is positioned within a growing cluster of universities, research institutes and commercial partners, enhancing long-term precinct success.
Helix Hub is for sale on a fund-through basis via Expressions of Interest closing 3pm, 9 April 2026 (AEST).
TPG Real Estate acquires €400 million European healthcare portfolio

TPG Real Estate Partners is acquiring a European healthcare portfolio from Canada's NorthWest Healthcare Properties REIT for approximately €400 million.
The portfolio, known as Project Nightingale, comprises 33 medical office and clinic assets totalling about 180,000 sq m in Germany and the Netherlands and is let to more than 400 tenants.
An acquisition loan of around €300 million is in place to support the transaction. The deal is expected to close in the second quarter of 2026, subject to customary closing conditions.
US bank Citi is understood to be providing the facility, which is arranged by JLL and is sized at a little over 70 per cent loan-to-value.
Trinity by Breakthrough reaches practical completion in Oxford

Trinity by Breakthrough has reached practical completion as a 214,000 sq ft Grade A laboratory and office building in Oxford developed by Breakthrough Properties.
The building provides purpose-built life sciences accommodation with an approximate 60:40 laboratory to office ratio and generous floorplates suitable for single or multiple occupiers.
Designed by architecture practice Niazi Roden, the scheme delivers new laboratory-ready space at the gateway to Oxford Business Park with integrated lab infrastructure and rooftop photovoltaic panels, and is being marketed to life sciences occupiers on a leasehold basis.
In addition to this newsletter, we deliver bespoke research and strategic analysis for investors and developers — from acquisition support to market mapping and custom reporting. Hit reply to discuss your next project.
Taoiseach opens Glassworks Building One in Waterford
Taoiseach (Prime Minister) Micheál Martin has opened Building One at Glassworks, an 80,000 sq ft enterprise block on the former Waterford Crystal manufacturing site in Kilbarry, developed by a joint venture between the Ireland Strategic Investment Fund and Waterford-based Frisby.
The €43 million building, which is expected to be more than 50 per cent let by next month, forms the first phase of a 37-acre enterprise and innovation campus beside South East Technological University, with capacity for up to 6,000 employees.
Planning permission has been granted for a 582-bed student development on adjacent lands.
Syngenta to invest $130 million in Jealott's Hill BioSTaR centre

Swiss-headquartered agrochemicals company Syngenta, wholly owned by Chinese state-owned Sinochem, plans to invest $130 million in a new Biological Sciences Technology and Research centre (BioSTaR) at its Jealott's Hill research and development hub in Bracknell, Berkshire.
The facility, expected to be operational in 2028, will accommodate 300 of the 800 scientists currently based at the site, focusing on molecular and analytical research alongside digital and AI applications for sustainable agriculture.
Opened in 1927 and owned by ICI for much of its history, Jealott's Hill is Syngenta's largest research facility globally.
👇 As a free member, you're seeing only 4 of 14 deals this week. Subscribers see them all — why not take a 14-day trial?
